Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Fennec Pharmaceuticals Inc. shareholders
As of Jun 30, 2026, 102 institutions reported holding Fennec Pharmaceuticals Inc., 46.5% of its shares. Largest: Rosalind Advisors, Inc., AIGH Capital Management LLC and Solas Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Fennec Pharmaceuticals Inc. | Change | Filed |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 3.19M | 9.1% | +280K | Aug 14, 2026 |
| AIGH Capital Management LLC | 2.49M | 7.1% | +505K | Aug 7, 2026 |
| Solas Capital Management, LLC | 1.89M | 5.4% | −593K | Aug 14, 2026 |
| BlackRock | 1.73M | 4.9% | +359K | Aug 7, 2026 |
| AWM Investment Company, Inc. | 1.16M | 3.3% | +440K | Aug 14, 2026 |
| Vanguard | 1.08M | 3.1% | −19,637 | Aug 13, 2026 |
| Prospect Capital Advisors, LLC | 498K | 1.4% | new | Aug 14, 2026 |
| State Street | 426K | 1.2% | +66,949 | Aug 7, 2026 |
| Geode Capital | 403K | 1.1% | +30,828 | Aug 12, 2026 |
| Jane Street | 234K | 0.67% | new | Aug 14, 2026 |